Clinical Study for Itolizumab in Lupus Nephritis Initiated in India Post DCGI Approval.
23-दिसंबर-2021
डाउनलोड पीडीएफ़
Biocon
Clinical Study for Itolizumab in Lupus Nephritis Initiated in India Post DCGI Approval.